Chemkart India Limited filed a regulatory statement confirming no deviation in IPO fund utilization for H1 FY26.
The company raised ₹64.48 crore through IPO with net proceeds of ₹54.68 crore allocated across three specific objects.
Fund utilization included ₹4.57 crore for manufacturing facility, full ₹20 crore for debt repayment, and ₹9.54 crore for corporate purposes.
Audit committee and statutory auditor Bagaria & Co LLP confirmed compliance with prospectus objectives and SEBI regulations.